Title:
Hetero ring compound
Document Type and Number:
Japanese Patent JP6130827
Kind Code:
B2
Abstract:
The invention relates to compounds of Formula I: wherein Ar1, Ar2, Ar3, L1, L2, Y, Z and v are defined in the specification, and pharmaceutically acceptable derivatives thereof, compositions comprising an effective amount of a compound of Formula I or a pharmaceutically acceptable derivative thereof, and methods for treating or preventing a condition such as pain, UI, an ulcer, IBD and IBS, comprising administering to an animal in need thereof an effective amount of a compound of Formula I or a pharmaceutically acceptable derivative thereof.
Inventors:
Noriyuki Kurose
Maki Fuchino
Kayoko Hata
Yasushi Imune
Naoko Yamaguchi
Xiao, Bin
Tafesse, Ray Care
Elephant, Xiao Ming
Yu, Jiang Min
Maki Fuchino
Kayoko Hata
Yasushi Imune
Naoko Yamaguchi
Xiao, Bin
Tafesse, Ray Care
Elephant, Xiao Ming
Yu, Jiang Min
Application Number:
JP2014511504A
Publication Date:
May 17, 2017
Filing Date:
May 16, 2012
Export Citation:
Assignee:
Shionogi Pharmaceutical Co., Ltd.
PURDUE PHARMA L.P.
PURDUE PHARMA L.P.
International Classes:
C07D413/14; A61K31/444; A61K31/4545; A61P1/00; A61P1/04; A61P1/10; A61P1/12; A61P13/10; A61P25/04; A61P29/00; A61P43/00; C07D401/14; C07D405/14; C07D413/10; C07D417/14
Domestic Patent References:
JP2010523726A | ||||
JP11139969A | ||||
JP2006528642A | ||||
JP2006528643A |
Foreign References:
WO2010064597A1 |
Attorney, Agent or Firm:
Hidesaku Yamamoto
Natsuki Morishita
Natsuki Morishita